Results 21 to 30 of about 48,894 (301)

Proactive Immunotherapeutic Approaches against Inflammatory Breast Cancer May Improve Patient Outcomes

Cells, 2022
Inflammatory breast cancer (IBC) is highly metastatic at the onset of the disease with no IBC-specific treatments, resulting in dismal patient survival. IBC treatment is a clear unmet clinical need.
Daniel Alonso-Miguel, Steven Fiering, Hugo Arias-Pulido   +2 more
doaj   +1 more source

Proof-of-Concept Preclinical Use of Drosophila melanogaster in the Initial Screening of Immunomodulators

Scientia Pharmaceutica, 2022
Drug discovery is a complex process, and the use of a comprehensive approach is deemed necessary to discover new chemical entities with novel mechanisms of action. This research was carried out to determine whether Drosophila melanogaster can serve as an
Firzan Nainu, Muh. Akbar Bahar, Sartini Sartini, Reski Amalia Rosa, Nur Rahmah, Reski Amelia Kamri, Nur Rahma Rumata, Risfah Yulianty, Elly Wahyudin   +8 more
doaj   +1 more source

Phages and Immunomodulation [PDF]

Future Microbiology, 2017
In the past years, the microbiome and its role in the pathophysiology of diseases have gained great interest. The progress of our knowledge in this field opens completely novel prospects for treating disorders, including those which are most challenging to medicine today.
Andrzej Górski, Dąbrowska, Krystyna, Ryszard Andrzej Międzybrodzki, Weber-Dąbrowska, Beata, Łusiak-Szelachowska, Marzanna, Jończyk-Matysiak, Ewa, Jan Jakub Borysowski   +6 more
openaire   +2 more sources

Canine atopic dermatitis: systemic immunomodulatory protocol based on clinical phenotype

Ciência Rural, 2023
: Canine atopic dermatitis (cAD) is a multifactorial allergic disease associated with immune dysfunction and abnormal skin barrier. Several immunological mediators play a role in its pathogenesis. Such molecules are produced by the activation of T helper
Tiago Cunha Ferreira, Marina Gabriela Monteiro Carvalho Mori da Cunha, Diana Célia Sousa Nunes-Pinheiro   +2 more
doaj   +1 more source

Repurposing Immunomodulatory Drugs to Combat Tuberculosis

Frontiers in Immunology, 2021
Tuberculosis (TB) is an infectious disease caused by an obligate intracellular pathogen, Mycobacterium tuberculosis (M.tb) and is responsible for the maximum number of deaths due to a single infectious agent.
Samreen Fatima, Ashima Bhaskar, Ved Prakash Dwivedi   +2 more
doaj   +1 more source

Immunomodulators: An Introduction

, 2023
Every year, the number of fish-bred goods increases across the world. In most cases, fish are raised in contained environments such as ponds or net cages.
Mauro M., Kollath A., Banaee M., Elumalai P., Falco F., Faggio C.   +5 more
core   +1 more source

Cancer and immunomodulators in inflammatory bowel diseases

, 2015
The widespread use of thiopurines and anti-tumor necrosis factors (TNFs) in inflammatory bowel disease (IBD) is a rising concern regarding their potential cancer risk.
CALABRESE, EMMA, PALLONE, FRANCESCO, Onali, S, ONALI, SARA, Biancone, L, BIANCONE, LIVIA, Calabrese, E, Pallone, F, Petruzziello, C   +8 more
core   +2 more sources

Synergistic Anticancer Activity of Fucoidan from Lessonia trabeculata Combined with Chemotherapeutic Agents in 4T1 Breast Spheroids

Marine Drugs
Triple-negative breast cancer (TNBC) is known for being aggressive and potentially resistant to chemotherapy. This means that new ways to improve cancer treatments are a priority.
Rosa María Condori Macuri, Libertad Alzamora-Gonzales, Erasmo Honorio Colona-Vallejos, Raisa Teresa Cruz Riquelme, Laura Inés Pecho Chávez, Jherson Oscar Cisneros Gutierrez, Victor Alonso Montejo Anlas   +6 more
doaj   +1 more source

Fucoidan from Lessonia trabeculata Induces Apoptosis through Caspase Dependent and Caspase-Independent Activation in 4T1 Breast Adenocarcinoma In Vitro

Marine Drugs
Experiments conducted on triple-negative breast cancer have shown that fucoidan from Lessonia trabeculata (FLt) exhibits cytotoxic and antitumor properties.
Raisa Teresa Cruz Riquelme, Erasmo Honorio Colona-Vallejos, Libertad Alzamora-Gonzales, Rosa María Condori Macuri   +3 more
doaj   +1 more source

New Routs In Optimization Therapy of Helicobacter Pylori Eradication in Patients with Chronic Duodenal Ulcer [PDF]

Саратовский научно-медицинский журнал, 2009
Pharmacological effects of immunomodulators produce normalization of immunochemical function of homeostasis. This phenomenon determines optimization of Helicobacter pylori eradication.
N.S. Khruleva, V.V. Dugina
doaj